UK markets closed

Tandem Diabetes Care, Inc. (0M0F.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
41.03+0.55 (+1.37%)
At close: 03:28PM GMT
Full screen
Previous close40.48
Open41.03
Bid0.00 x N/A
Ask0.00 x N/A
Day's range41.03 - 41.03
52-week range41.03 - 41.03
Volume780
Avg. volumeN/A
Market cap23.229M
Beta (5Y monthly)0.84
PE ratio (TTM)4.61
EPS (TTM)0.09
Earnings date22 Feb 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    2 Growth Stocks to Buy While They Are Still Down

    With that in mind, let's look at two growth stocks that fit the bill: Tandem Diabetes Care (NASDAQ: TNDM) and Fiverr (NYSE: FVRR). Medical device specialist Tandem Diabetes Care focuses on the diabetes market, as its name suggests. The company has been an innovator in the field, and right now, it makes money by selling its prized insulin pump, the t:slim X2.

  • Business Wire

    Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical

    SAN DIEGO, January 23, 2023--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced the completion of its previously announced acquisition of AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump. The Sigi Patch Pump, designed to be an ergonomic, rechargeable patch pump that reduces the burden of managing diabetes through its use of pre-filled insulin cartridges, is under development and not commercially available

  • Business Wire

    Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023

    SAN DIEGO, January 19, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2022 results after the financial markets close on Wednesday, February 22, 2023. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2022 financial and operating results.